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off-pump coronary bypass surgery: a randomized clinical trial. J Thorac Cardiovasc Surg. 2009;138:703-11.
We thank Drs McIlroy and Nishanian for their careful reading of our article. Investigation of the points that they raised revealed
several data entry errors. Correction of those errors reduced the average prothrombin time (international normalized ratio) for
the hetastarch group and its SD. After correction of the data entry error, the direction of the difference in average international
normalized ratio between hetastarch and albumin groups reversed, but that difference was still not statistically significant.
Table 1, corrected to address the error, follows.TABLE 1. Baseline characteristics of patients receiving hetastarch (study group) or albumin (control group)
Hetastarch Albumin Statistical test P value
Age (y, mean 6 SD) 64.1 6 9.8, n 5 78 64.4 6 9.0, n 5 78 Students t test 5 0.229, df 5 154 .82, NS
Sex (% male) 82.1%, n 5 78 70.5%, n 5 78 Fisher’s Exact test .13, NS
Body mass index (kg/m2,
mean 6 SD)
27.5 6 4.8, n 5 78 28.9 6 5.3, n 5 78 Student t test 5 1.65, df 5 154 .10, NS
Serum albumin level (g/dL,
mean 6 SD)
3.75 6 0.39, n 5 59 3.69 6 0.47, n 5 63 Student t test 5 20.83, df 5 120 .41, NS
Serum creatinine level (mg/dL,
mean 6 SD)
1.11 6 0.31, n 5 78 1.10 6 0.33, n 5 78 Student t test 5 20.23, df 5 154 .82, NS
Serum urea nitrogen level (mg/dL,
mean 6 SD)
19.76 6 8.61, n 5 78 18.32 6 6.91, n 5 78 Student t test 5 21.15, df 5 154 .25, NS
Hematocrit (%, mean 6 SD) 40.26% 6 4.18%, n 5 78 40.22% 6 4.39%, n 5 78 Student t test 5 20.052, df 5 154 .96, NS
Platelet count (3103 cells/mL,
mean 6 SD)
228.96 6 58.30, n 5 78 230.74 6 66.07, n 5 78 Student t test 5 0.18, df 5 154 .86, NS
Prothrombin time (international
normalized ratio, mean 6 SD)
1.06 6 0.11, n 5 78 1.07 6 0.10, n 5 78 Student t test 5 0.77, df 5 154 .44, NS
Activated partial thromboplastin
time (s, mean 6 SD)
38.56 6 36.11, n 5 78 33.02 6 15.73, n 5 78 Student t test 5 21.24,
df 5 105.21
.22, NS
Preoperative use of intravenous
heparin (%)
24.4%, n 5 78 30.8%, n 5 78 Fisher’s Exact test .47, NS
Preoperative use of low–
molecular-weight heparin (%)
15.4%, n 5 78 14.1%, n 5 78 Fisher’s Exact test ..999, NS
Preoperative use of glycoprotein
IIb/IIIa inhibitors (%)
10.3%, n 5 78 12.8%, n 5 78 Fisher’s Exact test .80, NS
Preoperative use of platelet
inhibitors (%)
3.8%, n 5 78 11.5%, n 5 78 Fisher’s Exact test .13, NS
Preoperative use of warfarin (%) 1.3%, n 5 78 1.3%, n 5 78 Fisher’s Exact test ..999, NS
Preoperative use of thrombolytic
agents (%)
3.8%, n 5 78 1.3%, n 5 78 Fisher’s Exact test .62, NS
NS, Not significant.
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